1. Post-menopausal women cut depression and anxiety by more than 75 percent with all-natural plant extract

    Depression and anxiety can hit post-menopausal women seemingly from out of the blue. This happens as hormone levels fall and a woman's body struggles to adjust to life without much estrogen. If this sounds like you, worry no more. A new study shows that post-menopausal women can cut their depression and anxiety by more than 75 percent by taking an all-natural and non-toxic plant extract.

    Plant used to treat hot flashes also boosts mood

    Scientists recruited 109 post-menopausal women with depression or anxiety. Half of the women received a placebo and the other half got an extract from the red clover plant every day for 90 days.

    Red clover is a plant that helps to purify the body of toxins. It also contains natural isoflavones, plant-based chemicals that act like estrogen in a woman's body, which is why so many women use it to cope with hot flashes during menopause. And now we know that red clover can even help stabilize a woman's mood following menopause.

    In fact, in the recent study, women who took 80 mg of red clover extract for 90 days cut their anxiety by 76 percent. They also cut their symptoms of depression by a whopping 80 percent! On the other hand, those women taking a placebo only cut their symptoms by about 20 percent.

    And here's the final bit of good news: unlike HRT (hormone replacement therapy), red clover is completely non-toxic and won't increase your risk of breast cancer. So just give it a try if you're post-menopausal with the occasional bout of depression or anxiety.

  2. Urgent Warning for Alzheimer Families

    If you have a family member suffering from Alzheimer’s disease, you know it’s not just a memory disorder. Alzheimer’s disease (AD) causes major behavior and mood disturbances.

    According to doctors, less than 10 percent of Alzheimer’s patients remained free from symptoms of “psychopathology” during the course of their disease. In other words, agitation, aggression, depression, anxiety, paranoid delusions, and insomnia are very much the norm for AD patients.

    As a result, today’s Alzheimer’s patient is all too often prescribed some type of antipsychotic drug to control their behavior. Thioridazine, chlorpromazine, haloperidol, trifluoperazine, or risperidone all belong to this class of drugs.

    Limited options for Alzheimer’s patients

    A new study to be published in Lancet Neurology, the respected British medical journal, confirms what one might guess about AD patients prescribed antipsychotics: the drugs shorten their lives.

    In fact, a patient taking an antipsychotic drug only has a 46 percent survival rate at 24 months (as compared to 71 percent for a patient taking a placebo). Moreover, only 30 percent of AD patients were alive at 36 months after having begun treatment with antipsychotics (as opposed to 59 percent taking a placebo).

    Bottom line here: if you’ve got a loved one with AD, think long and hard about using an antipsychotic drug to control their behavior. If you’ve run out of options, authors of the study suggest using the drugs for a limited time (3 months or less) to see if behavior improves.

2 Item(s)